Projects
Home > Projects > Ongoing > Additional Clinician Level Performance Measures
NQF Member comments due March 28, 2008 by 6:00 PM ET Public comments due March 21, 2008 by 6:00 PM ET
Comments are listed in the order they were submitted.
Infectious Disease - General Comments on the Report IF-001-07 Testing for Chronic Hepatitis C -Confirmation of Hepatitis C Viremia IF-002-07 Counseling Regarding Use of Contraception Prior to Antiviral Treatment IF-003-07 HCV RNA Testing Before Initiating Treatment (Paired w/004) IF-004-07 HCV Genotype Testing Prior to Treatment (Paired w/003) IF-005-07 Hepatitis C: Consideration for Antiviral Therapy IF-007-07 Hepatitis C: HCV RNA Testing at Week 12 of Treatment IF-008-07 Hepatitis C: Hepatitis A Vaccination (Paired w/ IF-009-07) IF-009-07 Hepatitis C: Hepatitis B Vaccination (Paired w/ IF-008-07) IF-010-07 Hepatitis C: Counseling Regarding Risk of Alcohol Consumption IF-024-07 Screening Foreign-Born Adults for Chronic Hepatitis B Peri-Operative Care - General Comments on the Report PO-001-07 Recording of Clinical Stage: Lung and Esophageal Cancer Resection PO-002-07 Participation in a National Database for General Thoracic Surgery PO-003-07 Recording of Performance Status Prior to Cancer Resection PO-004-07 Pulmonary Function Tests (PTF) Before Major Anatomic Lung Resection PO-005-07 Risk-Adjusted Morbidity: LOS>14 Days After Elective Lobectomy PO-006-07 Risk-adjusted morbidity and mortality for esophagectomy for cancer PO-009-07 Discontinuation of Prophylactic Antibiotics (Non-Cardiac Procedures) PO-010-07 Selection of Prophylactic Antibiotic 1st/2nd Generation Cephalosporin PO-011-07 Timing of Antibiotic Prophylaxis - Ordering Physician PO-012-07 Prevention of CRBI: CVC Insertion Protocol PO-014-07 Perioperative Anti-platelet Therapy for Patients undergoing CEA PO-017-07 PO Stroke/Death in Asymptomatic Patient undergoing CEA PO-018-07 Use of Patch During Conventional Endarterectomy Non-Physician Professionals - General Comments on the Report NP-001-07 Functional status change for patients with knee impairments NP-002-07 Functional status change for patients with hip impairments NP-003-07 Functional status change for patients with foot/ankle impairments NP-004-07 Functional status change for patients with lumbar spine impairments NP-005-07 Functional status change for patients with shoulder impairments NP-006-07 Functional status change: elbow, wrist or hand impairments NP-007-07 Functional status change: general orthopedic impairments NP-010-07 Diabetic Foot & Ankle Care, Neurological Evaluation NP-009-07 Diabetic Foot & Ankle Care, Ulcer Prevention - Evaluation of Footwear NP-011-07 Diabetic Foot & Ankle Care, PAD - Ankle Brachial Index (ABI) NP-012-07 Screening for Clinical Depression and Follow-up NP-014-07 Universal Documentation and Verification of Current Medications NP-015-07 Pain Assessment Prior to Initiation of Patient Therapy and Follow-up NP-017-07 Adult Weight Screening and Follow-Up NP-018-07 Patient Co-development of Plan of Care NP-033-07 Change in Basic Mobility as Measured by the AM-PAC NP-034-07 Change in Daily Activity Function as Measured by the AM-PAC Cancer Care - General Comments on the Report CA-001-07: Hematology: Baseline Cytogenetic Testing Performed CA-002-07: Hematology: Documentation of Iron Stores for Erythropoietin Therapy CA-003-07: Hematology: CLL - Baseline Flow Cytometry CA-004-07: Hematology: Multiple Myeloma - Treatment with Bisphosphonates CA-005-07: Radiation Oncology: Trt Summary Documented and Communicated CA-006-07: Medical Oncology: Radiation Dose Limits to Normal Tissues CA-007-07: Medical Oncology and Radiation Oncology: Plan of Care for Pain CA-017-07: Medical Oncology and Radiation Oncology: Pain Intensity Quantified CA-013-07: Medical Oncology: Chemotherapy for Colon Cancer Patients CA-015-07: Medical Oncology: Plan for Chemotherapy Documented CA-016-07: Medical Oncology: Hormonal therapy for breast cancer CA-008-07: Prostate Cancer: Three-Dimensional Radiotherapy CA-009-07: Prostate Cancer: Bone Scan for Staging Low-Risk Patients CA-010-07: Prostate Cancer: Adjuvant Hormonal Therapy for High-Risk Patients CA-011-07: Prostate Cancer: Initial Evaluation CA-012-07:Prostate Cancer: Treatment Options for Patients w/Localized Disease CA-018-07: Pathology: Breast Cancer Resection Pathology Reporting CA-019-07: Pathology: Colorectal Cancer Resection Pathology Reporting
Copyright © 2008 The National Quality Forum. All Rights Reserved. Privacy Policy / Terms of Use
601 13th Street NW, Suite 500 North, Washington DC 20005
Site Map